Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System
March 12, 2026
Medical Diagnostics & Screening
-
-
Prenetics Authorizes $40 Million Share Repurchase Program
March 6, 2026
-
Exagen Inc. to Participate in Upcoming Investor Conferences
March 3, 2026
-
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry
February 25, 2026
-
Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives
February 25, 2026
-
Prenetics Launches IM8 Daily Ultimate Essentials PRO – A Clinical Formula with Two New Flavours
February 23, 2026
-
Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
February 18, 2026
-
MBody AI ($CHEK) Secures 98% Shareholder Approval to Become Leading Nasdaq Embodied AI Company
November 17, 2025
-
Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock
November 14, 2025
-
Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy
October 27, 2025
-
ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings
October 23, 2025
-
VolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants
October 10, 2025
-
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection
May 22, 2025
-
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra
March 27, 2025
-
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch
March 25, 2025
-
CENTOGENE Closes Strategic Transaction with Private Equity Group Charme Capital Partners
March 12, 2025